Ursula
Ursula Busse, Sillery CA
Patent application number | Description | Published |
---|---|---|
20080261228 | PCA3 Messenger RNA Species in Benign and Malignant Prostate Tissues - This invention concerns the discovery of two distinct PCA3 mRNA sequences. One of these sequences corresponds to a short PCA3 mRNA molecule whereas the other PCA3 RNA molecule is longer as it comprises an additional sequence between exon 3 and exon 4a. The short RNA is associated with prostate cancer whereas the long RNA sequence is associated with a non-malignant state of the prostate. Based on the differential expression levels of these two PCA3 RNA sequences, protocols for the diagnosis of prostate disease are provided. The invention also relates to therapeutic approaches to prostate cancer. | 10-23-2008 |
Ursula Busse, Saint-Louis FR
Patent application number | Description | Published |
---|---|---|
20100129824 | DISTINGUISHING PCA3 MESSENGER RNA SPECIES IN BENIGN AND MALIGNANT PROSTATE TISSUES - This invention concerns the discovery of two distinct PCA3 mRNA sequences. One of these sequences corresponds to a short PCA3 mRNA molecule whereas the other PCA3 RNA molecule is longer as it comprises an additional sequence between exon 3 and exon 4a. The short RNA is associated with prostate cancer whereas the long RNA sequence is associated with a non-malignant state of the prostate. Based on the differential expression levels of these two PCA3 RNA sequences, protocols for the diagnosis of prostate disease are provided. The invention also relates to therapeutic approaches to prostate cancer. | 05-27-2010 |
20110212449 | DISTINGUISHING PCA3 MESSENGER RNA SPECIES IN BENIGN AND MALIGNANT PROSTATE TISSUES - This invention concerns the discovery of two distinct PCA3 mRNA sequences. One of these sequences corresponds to a short PCA3 mRNA molecule whereas the other PCA3 RNA molecule is longer as it comprises an additional sequence between exon 3 and exon 4a. The short RNA is associated with prostate cancer whereas the long RNA sequence is associated with a non-malignant state of the prostate. Based on the differential expression levels of these two PCA3 RNA sequences, protocols for the diagnosis of prostate disease are provided. The invention also relates to therapeutic approaches to prostate cancer. | 09-01-2011 |
20120315634 | DISTINGUISHING PCA3 MESSENGER RNA SPECIES IN BENIGN AND MALIGNANT PROSTATE TISSUES - This invention concerns the discovery of two distinct PCA3 mRNA sequences. One of these sequences corresponds to a short PCA3 mRNA molecule whereas the other PCA3 RNA molecule is longer as it comprises an additional sequence between exon 3 and exon 4a. The short RNA is associated with prostate cancer whereas the long RNA sequence is associated with a non-malignant state of the prostate. Based on the differential expression levels of these two PCA3 RNA sequences, protocols for the diagnosis of prostate disease are provided. The invention also relates to therapeutic approaches to prostate cancer. | 12-13-2012 |
20140087384 | DISTINGUISHING PCA3 MESSENGER RNA SPECIES IN BENIGN AND MALIGNANT PROSTATE TISSUES - This invention concerns the discovery of two distinct PCA3 mRNA sequences. One of these sequences corresponds to a short PCA3 mRNA molecule whereas the other PCA3 RNA molecule is longer as it comprises an additional sequence between exon 3 and exon 4a. The short RNA is associated with prostate cancer whereas the long RNA sequence is associated with a non-malignant state of the prostate. Based on the differential expression levels of these two PCA3 RNA sequences, protocols for the diagnosis of prostate disease are provided. The invention also relates to therapeutic approaches to prostate cancer. | 03-27-2014 |
Ursula Canci, Staten Island, NY US
Patent application number | Description | Published |
---|---|---|
20100050320 | Hosiery with removable foot cushion - Footwear hosiery is provided, which includes a first layer defining a front portion, an arch portion and a rear portion. A second layer is connected with at least one of the arch portion and the front portion in a configuration to define a receptacle having an opening. A pad is configured for removable disposal within the receptacle. The first layer may be a fabric material. The second layer may be fabricated from a flexible material. | 03-04-2010 |
20120227161 | HOSIERY WITH REMOVABLE FOOT CUSHION - Footwear hosiery is provided, which includes a first layer defining a front portion, an arch portion and a rear portion. A second layer is connected with at least one of the arch portion and the front portion in a configuration to define a receptacle having an opening. A pad is configured for removable disposal within the receptacle. The first layer may be a fabric material. The second layer may be fabricated from a flexible material. | 09-13-2012 |
Ursula Dahmen-Levison, Berlin DE
Patent application number | Description | Published |
---|---|---|
20110262936 | METHOD OF DETERMINING A CONCENTRATION OF ANALYTES OF INTEREST IN A SAMPLE - A method of determining a concentration of analytes of interest in a sample reaction mixture is disclosed. The method can include measuring intensities of the polarized fluorescence of at least one comparative reaction mixture containing different, known amounts of the analytes of interest, and measuring the intensities of the polarized fluorescence of a sample reaction mixture. The method can also include determining the preliminary concentrations of the analytes of interest in the sample reaction mixture by comparing the measured intensities of the sample reaction mixtures at various time points. The margin of error for the preliminary concentration of the analytes of interest in the sample can be determined at the various time points. Finally, the concentration of the analytes of interest in the sample reaction mixture can be determined by comparing the preliminary concentrations and the respective margin of error at the given time points. | 10-27-2011 |
Ursula Ebels, Grenoble FR
Patent application number | Description | Published |
---|---|---|
20100003421 | METHOD OF FABRICATING A NANOSTRUCTURE ON A PRE-ETCHED SUBSTRATE - The present invention relates to a method of fabricating a nanostructure, comprising the following steps: prestructuring a substrate ( | 01-07-2010 |
20100039181 | SPIN-TRANSFER TORQUE OSCILLATOR - The invention relates to a method of operating a spin-transfer torque structure to generate voltage oscillations, said structure comprising a first layer of magnetic material having a fixed magnetization vector, a spacer of non magnetic material and a second layer of magnetic material having a free magnetization vector. The method includes the application of a current (j | 02-18-2010 |
20110007560 | SPIN POLARISED MAGNETIC DEVICE - A magnetic device includes a magnetic reference layer with a fixed magnetisation direction located either in the plane of the layer or perpendicular to the plane of the layer, a magnetic storage layer with a variable magnetisation direction, a non-magnetic spacer separating the reference layer and the storage layer and a magnetic spin polarising layer with a magnetisation perpendicular to that of the reference layer, and located out of the plane of the spin polarising layer if the magnetisation of the reference layer is directed in the plane of the reference layer or in the plane of the spin polarising layer if the magnetisation of the reference layer is directed perpendicular to the plane of the reference layer. The spin transfer coefficient between the reference layer and the storage layer is higher than the spin transfer coefficient between the spin polarising layer and the storage layer. | 01-13-2011 |
20110109397 | RADIOFREQUENCY OSCILLATOR - This radiofrequency oscillator has a free layer ( | 05-12-2011 |
20120075031 | SPIN-VALVE OR TUNNEL-JUNCTION RADIO-FREQUENCY OSCILLATOR, PROCESS FOR ADJUSTING THE FREQUENCY OF SUCH AN OSCILLATOR AND NETWORK CONSISTING OF A PLURALITY OF SUCH OSCILLATORS - A radio-frequency oscillator incorporates a magnetoresistive device within which an electron current is able to flow. The device includes a stack including: a magnetic trapped layer, the magnetization of which is of substantially fixed direction; a magnetic free layer; and a non-magnetic intermediate layer-interposed between the free layer and the trapped layer. The oscillator also includes a mechanism capable of making an electron current flow in the layers constituting the stack and in a direction perpendicular to the plane which contains the layers. At least the free layer is devoid of any material at its center. The electron current density flowing through the stack is capable of generating a magnetization in the free layer in a micromagnetic configuration in the shape of a skewed vortex flowing in the free layer around the center of the free layer. | 03-29-2012 |
20120268172 | OSCILLATION DETECTOR - An oscillation detector having an RF oscillator configured to be synchronized with a first frequency and a comparator for distinguishing the synchronized state from the non-synchronized state of the radiofrequency oscillator on the basis of an oscillating signal produced by the radiofrequency oscillator and indicating the presence of oscillations in a frequency band around the first frequency in response to identifying the synchronized state and, in alternation, indicating the absence of oscillations in this frequency band otherwise. | 10-25-2012 |
20120270515 | DEMODULATOR OF A FREQUENCY-MODULATED ELECTRICAL SIGNAL - A demodulator of an FM signal modulated about a carrier frequency with a modulation frequency has an RF oscillator configured to be synchronized, under identical conditions of operation, with oscillations at first and second frequencies used in the FM signal to encode respective pieces of information. The oscillator has a magnetoresistive device; and a low-pass filter connected to an output electrode of the magnetoresistive device to filter an oscillating signal, generated by the oscillator and to a rendering terminal to provide, as a demodulated electrical signal, the filtered signal, the cut-off frequency f | 10-25-2012 |
20130002362 | MAGNETORESISTIVE RADIOFREQUENCY OSCILLATOR - A radiofrequency oscillator comprises: a free layer ( | 01-03-2013 |
20130057356 | MAGNETORESISTIVE RADIOFREQUENCY OSCILLATOR AND METHOD FOR GENERATING AN OSCILLATING SIGNAL - The invention relates to a radio frequency oscillator which incorporates: a spin-polarized electric current magnetoresistive device ( | 03-07-2013 |
20130057357 | MAGNETORESISTIVE RADIOFREQUENCY OSCILLATOR AND METHOD FOR GENERATING AN OSCILLATING SIGNAL - The invention relates to a radiofrequency oscillator which incorporates: a spin-polarized electric current magnetoresistive device ( | 03-07-2013 |
Ursula Elsaesser-Beile, Denzlingen DE
Patent application number | Description | Published |
---|---|---|
20090041789 | Monoclonal Antibodies and Single Chain Antibody Fragments Against Cell-Surface Prostate Specific Membrane Antigen - Isolated monoclonal antibodies or an antigen binding portion thereof which bind to prostate specific membrane antigen in its native form occurring on the surface of tumor cells characterized in that it is linked to a label or a cytotoxic agent or constructed as a part of a bispecific antibody or a recombinant diabody. | 02-12-2009 |
Ursula Elsässer-Beile, Denzlingen DE
Patent application number | Description | Published |
---|---|---|
20120231024 | MONOCLONAL ANTIBODIES AND SINGLE CHAIN ANTIBODY FRAGMENTS AGAINST CELL-SURFACE PROSTATE SPECIFIC MEMBRANE ANTIGEN AS DIAGNOSTIC AND THERAPEUTIC TOOLS FOR PROSTATE CANCER - Isolated monoclonal antibodies or an antigen binding portion thereof which bind to prostate specific membrane antigen in its native form occurring on the surface of tumor cells characterized in that it is linked to a label or a cytotoxic agent or constructed as a part of a bispecific antibody or a recombinant diabody. | 09-13-2012 |
Ursula Fattler, Lorrach DE
Patent application number | Description | Published |
---|---|---|
20130259922 | LIPOSOMAL FORMULATIONS OF LIPOPHILIC COMPOUNDS - The present invention relates to the preparation of liposomes with enhanced loading capacity for pharmaceutically and/or diagnostically active agents and/or cosmetic agents which are substantially solubilized by the liposomal membranes, to liposome dispersions with enhanced stability with respect to release of the active agent and/or cosmetic agent from the liposomes obtainable by the process, and to pharmaceutical or cosmetic compositions comprising said stabilized liposome dispersions. The preparation may involve dehydration and rehydration steps of liposome dispersions which may be carried out by spray drying. | 10-03-2013 |
Ursula Fattler, Riehen CH
Patent application number | Description | Published |
---|---|---|
20120100067 | Solubilisation Method - The present invention relates to the solubilisation of an active agent in a lipid dispersion, in particular to the solubilisation of an active agent in a suspension of preformed empty liposomes. | 04-26-2012 |
Ursula Fritzmeier, Grosshelfendorf DE
Patent application number | Description | Published |
---|---|---|
20120156759 | METHOD AND PRODUCT FOR DECOMPOSING ORGANIC COMPOUNDS - A method for the biological decomposition of organic compounds of the group of hydrocarbons, fats, oils, waxes, and derivatives thereof as well as mixtures thereof in media polluted therewith, in the presence of at least one dispersant, wherein the medium polluted with the pollutants is treated with at least one dispersant and with microorganisms. | 06-21-2012 |
Ursula Garczarek, Dortmund DE
Patent application number | Description | Published |
---|---|---|
20090286328 | USE OF PROTEIN S100A12 AS A MARKER FOR COLORECTAL CANCER - The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein S100A12 in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a stool sample, derived from an individual by measuring S100A12 in said sample. Measurement of S100A12 can, e.g., be used in the early detection or diagnosis of colorectal cancer. | 11-19-2009 |
20100159479 | TIMP-1 AS A MARKER FOR COLORECTAL CANCER - The present invention relates to the diagnosis of colorectal cancer. It discloses the use of protein TIMP-1 (tissue inhibitor of metalloproteinase 1) as a marker molecule in the diagnosis of colorectal cancer. It relates to a method for diagnosis of colorectal cancer from a stool sample, derived from an individual, the method involving measuring TIMP-1 in the sample. Measurement of TIMP-1 can, e.g., be used in the early detection or diagnosis of colorectal cancer. | 06-24-2010 |
20100240068 | MARKER PANEL FOR COLORECTAL CANCER - The present invention relates to a method for assessing colorectal cancer (CRC) in vitro including measuring in a sample the concentration and/or activity of a seprase polypeptide and/or fragments thereof and of either anti-p53 and/or osteopontin and/or ferritin, of optionally one or more other marker of CRC, and using the combined measurement result in the assessment of CRC. Furthermore, it especially relates to a method for assessing CRC from a liquid sample, derived from an individual by measuring seprase and at least anti-p53, ferritin and/or osteopontin in the sample. The method according to the present invention can, e.g., be used in the early detection of cancer by screening of asymptomatic individuals or in the surveillance of patients who undergo surgery. | 09-23-2010 |
20110129860 | CALPROTECTIN AND HEMOGLOBIN/HAPTOGLOBIN COMPLEX FROM STOOL SAMPLE TO ASSESS COLORECTAL CANCER - The present invention relates to a method aiding in the assessment of colorectal cancer. The method especially is used in assessing the absence or presence of colorectal cancer in vitro. The method is for example practiced by analyzing biochemical markers, comprising measuring in a stool sample the concentration of the hemoglobin/haptoglobin complex and calprotectin and correlating the concentrations determined to the absence or presence of colorectal cancer. To further improve the assessment of colorectal cancer based on a method of this invention the level of one or more additional marker may be determined together with the hemoglobin/haptoglobin complex and calprotectin in a stool sample and be correlated to the absence or presence of colorectal cancer. The invention also relates to the use of a marker panel comprising the hemoglobin/haptoglobin complex and calprotectin in the early diagnosis of colorectal cancer and it teaches a kit for performing the method of the invention. | 06-02-2011 |
Ursula Gebhardt, Sint Lambrechts Woluwe BE
Patent application number | Description | Published |
---|---|---|
20090198295 | Intravascular Medical Device - An implantable medical device is configured so that all of the major components including a housing and attached leads are disposed within the vasculature of a patient. A tether extends from the housing of the device to an implant location where the tether is secured to tissue outside of the vasculature. In this manner, an intravascular medical device may be implanted at a location remote from final placement, delivered via the vasculature and anchored at the initial entry point. | 08-06-2009 |
20100137936 | INTRAVASCULAR MEDICAL DEVICE - An implantable medical device is configured so that all of the major components including a housing and attached leads are disposed within the vasculature of a patient. A tether extends from the housing of the device to an implant location where the tether is secured to tissue outside of the vasculature. In this manner, an intravascular medical device may be implanted at a location remote from final placement, delivered via the vasculature and anchored at the initial entry point. | 06-03-2010 |
Ursula Ginster, Tuscon, AZ US
Patent application number | Description | Published |
---|---|---|
20110185897 | REMOVAL OF CARBON DIOXIDE FROM AIR - The present invention is directed to methods for removing CO | 08-04-2011 |
Ursula Golchert, Dieburg DE
Patent application number | Description | Published |
---|---|---|
20090043044 | METHOD FOR PRODUCTION OF BEAD POLYMERS WITH AN AVERAGE PARTICLE SIZE IN THE RANGE OF 1 MICROMETER TO 40 MICROMETERS AND MOULDED MASSES AND MOULDED BODIES COMPRISING BEAD POLYMERS - Process for preparation of bead polymers whose average particle size is in the range from 1 μm to 40 μm, by dispersing and polymerizing a polymerizable composition in an aqueous phase, where the dispersion stabilized by an aluminium compound is prepared at a shear rate ≧10 | 02-12-2009 |
20090105399 | TRANSPARENT TPU (THERMOPLASTIC POLYURETHANES)/PMMA (POLYMETHYL (METH) ACRYLATE) BLENDS WITH IMPROVED LOW-TEMPERATURE IMPACT RESISTANCE - The invention describes transparent plastics mixtures having low-temperature impact resistance composed of a thermoplastic polyurethane (TPU) and of an impact-modified poly(meth)acrylate (PMMA). | 04-23-2009 |
20090176928 | SUBDUEDLY COLORED, INFRARED REFLECTING PLASTIC COMPOUND - The invention relates to subduedly colored (brown, gray, black, green), infrared reflecting PMMA compounds which can be applied to other plastic compounds as an IR barrier layer | 07-09-2009 |
20100098907 | MOLDING COMPOUND FOR MATT MOLDED POLYACRYLATE BODIES - Moulding composition, comprising, based in each case on the total weight of the moulding composition, | 04-22-2010 |
20100098908 | MOULDING COMPOSITIONS FOR MATT PMMI MOULDINGS - Moulding composition, comprising, in each case based on the total weight of the moulding composition, | 04-22-2010 |
20100272960 | MOLDED BODY HAVING MATT AND STRUCTURED SURFACE PROPERTIES - Composition for the production of mouldings having a matt and structured surface character, comprising a polymer matrix and crosslinked polymer particles, the polymer matrix comprising at least one acrylic polymer and the composition containing | 10-28-2010 |
20110136964 | COLORING PROCESS FOR POLY (METH) ACRYLATES WITH WATER-BASED LIQUID DYES AND WATER-BASED LIQUID DYES - The invention relates to an aqueous colorant preparation for coloring thermoplastic plastics. | 06-09-2011 |
20110230610 | POLYMER BLEND FOR MATTE INJECTION MOULDED PARTS - The invention relates to a polymer mixture, comprising | 09-22-2011 |
20120108735 | PROCESS AND SYSTEM FOR COLOURING PLASTICS MOULDING COMPOSITIONS - The present invention relates to a process for producing coloured plastics moulding compositions with aqueous liquid colours, where an aqueous liquid colour is added to a molten plastics moulding composition. | 05-03-2012 |
20120282396 | OPAQUELY COLORED, INFRA-RED PLASTICS MOLDING COMPOSITION AND METHODS OF MAKING THE OPAQUELY COLORED, INFRA-RED PLASTICS MOLDING COMPOSTION - The invention relates to subduedly colored (brown, gray, black, green), infrared reflecting PMMA compounds which can be applied to other plastic compounds as an IR barrier layer | 11-08-2012 |
20130096244 | WATER-BASED LIQUID COLOR CONTAINING THERMOSTABLE DISPERSION ADDITIVES FOR THE COLORING POLY(METH)ACRYLATES - The invention relates to a method for coloring thermoplastic molding compounds, preferably a polymethyl(meth)acrylate molding compound, using novel aqueous colorant preparations. The invention further relates to a novel water-based colorant preparation. | 04-18-2013 |
20130203918 | WEATHERING-RESISTANT, COLORED MOLDINGS WITH IMPROVED GLOSS AND WIPE RESISTANCE - The present invention relates to weathering-resistant, colored moldings made of poly(alkyl) (meth)acrylate with improved gloss and resistance to mechanical influences acting on the surface of the molding, in particular with improved wipe resistance and improved scratch resistance, and also to molding compositions for producing the same. | 08-08-2013 |
Ursula Gompels, London GB
Patent application number | Description | Published |
---|---|---|
20110098212 | CYTOKINE - A novel cytokine, U83A, is described, as are variant forms of the cytokine, having a wide range of agonistic and antagonistic activity against chemokine receptors. Uses of the chemokine in treatment of a range of diseases, including cancers and HIV/AIDS, are described. | 04-28-2011 |
Ursula Greferath, Victoria AU
Patent application number | Description | Published |
---|---|---|
20080255044 | Method of treatment - The present invention relates generally to a method of treatment and in particular a method of treating disorders of the nervous system such as arising from or during disease or injury. The method of the present invention involves manipulating expression of Eph receptors or their functional equivalents to increase or decrease expression or function depending on the condition being treated. | 10-16-2008 |
Ursula Grocke, Novelty, OH US
Patent application number | Description | Published |
---|---|---|
20080203186 | MISTING DEVICE - A misting device capable of selectively spraying a fluid mist to cool an area or an individual(s) and/or promote health and wellness of the individual(s). The misting device includes a body, a pump and one or more fluid reservoirs disposed in the body, a spray arm extending from the body, and one or more misting nozzles supported by the spray arm. The body is adapted to support the device on a surface and the spray arm and nozzles are movable to adjust the direction of the mist exiting the nozzles. | 08-28-2008 |
Ursula Hedenig, Villach AT
Patent application number | Description | Published |
---|---|---|
20130313661 | Method for Processing a Wafer at Unmasked Areas and Previously Masked Areas to Reduce a Wafer Thickness - A method for processing a wafer having microelectromechanical system structures at the first main surface includes applying a masking material at the second main surface and structuring the masking material to obtain a plurality of masked areas and a plurality of unmasked areas at the second main surface. The method further includes anisotropically etching the wafer from the second main surface at the unmasked areas to form a plurality of recesses. The masking material is then removed at least at some of the masked areas to obtain previously masked areas. The method further includes anisotropically etching the wafer from the second main surface at the unmasked areas and the previously masked areas to increase a depth of the recesses and reduce a thickness of the wafer at the previously masked areas. | 11-28-2013 |
20140027915 | PRODUCTION OF ADHESION STRUCTURES IN DIELECTRIC LAYERS USING PHOTOPROCESS TECHNOLOGY AND DEVICES INCORPORATING ADHESION STRUCTURES - In various aspects of the disclosure, a semiconductor device including at least one semiconductor die; a dielectric layer adjoining the semiconductor die; geometric structures formed in the dielectric layer; and a conductive layer deposited over the dielectric layer, wherein the conductive layer is at least partially located over the geometric structures. | 01-30-2014 |
20140061677 | Opto-Electronic Sensor - Some embodiments of the present disclosure relate to an infrared (IR) opto-electronic sensor having a silicon waveguide implemented on a single silicon integrated chip. The IR sensor has a semiconductor substrate having a silicon waveguide extends along a length between a radiation input conduit and a radiation output conduit. The radiation input conduit couples radiation into the silicon waveguide, while the radiation output conduit couples radiation out from the silicon waveguide. The silicon waveguide conveys the IR radiation from the radiation input conduit to the radiation output conduit at a single mode. As the radiation is conveyed by the silicon waveguide, an evanescent field is formed that extends outward from the silicon waveguide to interact with a sample positioned between the radiation input conduit and the radiation output conduit. | 03-06-2014 |
20140335700 | Carbon Layers for High Temperature Processes - Carbon layers with reduced hydrogen content may be deposited by plasma-enhanced chemical vapor deposition by selecting processing parameters accordingly. Such carbon layers may be subjected to high temperature processing without showing excessive shrinking. | 11-13-2014 |
Ursula Herbstreith, Rastatt DE
Patent application number | Description | Published |
---|---|---|
20100192619 | Temperature conditioning device for a food transport container - In order to provide a temperature conditioning device for a food transport container for conditioning air disposed in an internal space of a container body of the food transport container with respect to its temperature that is user-friendly and easy to maintain, it is proposed that in a closed state of the food transport container the temperature conditioning device is insertable from the exterior of the container body into a wall of the container body of the food transport device and removable therefrom. | 08-05-2010 |
Ursula Herzog-Denu, Baden-Baden DE
Patent application number | Description | Published |
---|---|---|
20080249915 | SECURE, OBJECTIVE ONLINE EXCHANGE, CONFIRMATION AND EVALUATION METHODS - The present invention provides a method for facilitating a trade between a buyer and a seller of a product, the seller offering a product for sale at a predetermined price; the buyer purchasing the product; determining buyer's sufficient currency status or insufficient currency status. If the buyers account has a sufficient currency status, holding monies in an amount equal to the predetermined price are transferred into a holding account; requiring the seller to verify the date of receipt of the monies; requesting the seller to verify the shipping status of the product within a shipping confirmation response time frame; requesting the buyer to verify the receipt status of the product within a receipt confirmation response time frame; and assigning a conduct value to the buyer and seller. | 10-09-2008 |
Ursula Hohlneicher, Molndal SE
Patent application number | Description | Published |
---|---|---|
20120122933 | Compounds - The present invention relates to a novel crystalline form of esomeprazole sodium salt. Further, the present invention also relates to the use of the novel crystalline form for the treatment of gastrointestinal disorders, pharmaceutical compositions containing it as well as processes for the preparation of the novel crystalline form. | 05-17-2012 |
Ursula Hohlneicher, Mölndal DE
Patent application number | Description | Published |
---|---|---|
20080249134 | New Esomeprazole Sodium Salt Crystal Modification - The present invention relates to a novel crystalline form of esomeprazole sodium salt. Further, the present invention also relates to the use of the novel crystalline form for the treatment of gastrointestinal disorders, pharmaceutical compositions containing it as well as processes for the preparation of the novel crystalline form. | 10-09-2008 |
Ursula Hohlneicher, Mölndal DE
Patent application number | Description | Published |
---|---|---|
20080249134 | New Esomeprazole Sodium Salt Crystal Modification - The present invention relates to a novel crystalline form of esomeprazole sodium salt. Further, the present invention also relates to the use of the novel crystalline form for the treatment of gastrointestinal disorders, pharmaceutical compositions containing it as well as processes for the preparation of the novel crystalline form. | 10-09-2008 |
Ursula Hollwedel, Schnaittach DE
Patent application number | Description | Published |
---|---|---|
20100012154 | METHOD FOR REMOVING DEPOSITS CONTAINING MAGNETITE AND COPPER FROM CONTAINERS IN INDUSTRIAL AND POWER PLANTS - A method to remove deposits containing magnetite and copper from a container, particularly from a steam generator of a nuclear power plant. In a first step, the container is treated using an alkaline cleaning solution containing a complexing agent forming a soluble complex with iron ions, a reducing agent, and an alkalizing agent. In a second step a further complexing agent forming a more stable complex with iron III ions than the complexing agent used in the first step and an oxidant are added to the cleaning solution of the first step present in the container. | 01-21-2010 |
20100313913 | METHOD FOR CLEANING A HEAT EXCHANGER - A physical-chemical method for cleaning a secondary chamber of a heat exchanger in a nuclear facility, includes drying the secondary chamber and introducing a cleaning solution into the secondary chamber to treat deposits present in the secondary chamber. | 12-16-2010 |
Ursula Holtzmann, Hamburg DE
Patent application number | Description | Published |
---|---|---|
20090209651 | USE OF 3-(4-HYDROXY-3-METHOXYPHENYL)-1-(4-HYDROXYPHENYL) PROPANE-1-ONE FOR IMPROVED SKIN CONTOURING OR AGAINST CELLULITE - A cosmetic or dermatological preparation which is suitable for application to skin and comprises 3-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-propane-1-one in a concentration which is effective for at least one of increasing skin moisture content, moisturizing skin, improving the surface structure of the skin, reducing cellulite, increasing the resilience and elasticity of skin, strengthening the connective tissue of skin, and reducing stretch marks on skin. This Abstract is not intended to define the invention disclosed in the specification, nor intended to limit the scope of the invention in any way. | 08-20-2009 |
Ursula Huber-Moulliet, Frankenthal DE
Patent application number | Description | Published |
---|---|---|
20100122379 | Active Ingredient Compositions for Plant Protection - The present invention relates to novel active substance compositions for plant protection in the form of finely divided active-substance-containing particles which compositions comprise | 05-13-2010 |
20100204045 | Systemicity Enhancers - A copolymer obtainable by polymerization of | 08-12-2010 |
20140272565 | PROTECTED ELECTRODE STRUCTURES - An electrode structure and its method of manufacture are disclosed. The disclosed electrode structures may be manufactured by depositing a first release layer on a first carrier substrate. A first protective layer may be deposited on a surface of the first release layer and a first electroactive material layer may then be deposited on the first protective layer. | 09-18-2014 |
Ursula Jeffry, Redwood City, CA US
Patent application number | Description | Published |
---|---|---|
20080260732 | CHIMERIC AND HUMANIZED ANTIBODIES TO ALPHA5BETA1 INTEGRIN THAT MODULATE ANGIOGENESIS - The present invention provides chimeric and humanized antibodies that specifically recognize α5β1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of the antibodies and pharmaceutical compositions including the same. | 10-23-2008 |
20090041785 | USE OF ANTI-INTEGRIN ANTIBODIES FOR REDUCING SCAR TISSUE FORMATION - The present invention provides methods that enable the user to identify inhibitors of tissue granulation in and around a wound site, thereby limiting excessive scar formation as the wounded tissue heals. The some granulation inhibitors identified using the methods of the invention inhibit granulation in and around a wound site up to five fold, with a corresponding decrease in the formation of scar tissue when tested on retinal injuries. Granulation inhibitors that can be identified using the methods of the present invention include antibodies, peptides, nucleic acids (aptamers), and non-peptide small molecules. | 02-12-2009 |
20090259031 | CHIMERIC AND HUMANIZED ANTIBODIES TO alpha5beta1 INTEGRIN THAT MODULATE ANGIOGENESIS - The present invention provides chimeric and humanized antibodies that specifically recognize α5β1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of the antibodies and pharmaceutical compositions including the same. | 10-15-2009 |
20110300133 | CHIMERIC AND HUMANIZED ANTIBODIES TO ALPHA5BETA1 INTEGRIN THAT MODULATE ANGIOGENESIS - The present invention provides chimeric and humanized antibodies that specifically recognize α5β1 integrin, and methods for using the antibodies for reducing or inhibiting angiogenesis in a tissue. Also provided are methods of determining therapeutically acceptable doses of the antibodies and pharmaceutical compositions including the same. | 12-08-2011 |
Ursula Keller, Ursula CH
Patent application number | Description | Published |
---|---|---|
20140016185 | SEMICONDUCTOR DISK LASER FOR NONLINEAR MICROSCOPY APPLICATIONS IN LIVING ORGANISMS - A mode locked semiconductor disk laser with an output beam having an ultra-short pulse length which provides the incident beam to a non linear microscope. The wavelength of the beam is at or near the action cross section maximum absorption wavelength for creating two photon excited fluorescence of a fluorescent biological marker in a sample. Semiconductor disk lasers combine excellent beam quality and output power, stability while maintaining simplicity and easiness of operation. In addition, these types of lasers are ideally suited for mass production as they are built in wafer-scale technology enabling a high level of integration. Importantly this non expensive, turn-key, compact laser system could be used as a platform to develop portable non-linear bio-imaging devices for clinical studies, facilitating its wide-spread adoption in “real-life” applications. | 01-16-2014 |
Ursula Kienzl, Zurich CH
Patent application number | Description | Published |
---|---|---|
20090324707 | METHOD FOR SYNTHESIZING CONFORMATIONALLY CONSTRAINED PEPTIDES, PEPTIDOMIMETICS AND THE USE THEREOF AS SYNTHETIC VACCINES - The present invention relates to methods for synthesizing conformationally constrained peptides and cyclic peptidomimetics obtainable by these methods which are conformationally constrained due an internal cross-link. This cross-link is formed between the side chain of an amino acid residue or analog and a (2S, 4S)4-functionalized proline residue. The invention further relates to the use of (2S, 4S)-4-functionalized proline residues as building units in the synthesis of such peptidomimetics and to the use thereof as antigens, alone or in combination with suitable immunopotentiating delivery systems, for example immunopotentiating reconstituted influenza virosomes to elicit an immune response in a mammal. Moreover, the invention also relates to pharmaceutical compositions containing the same. | 12-31-2009 |
20110008414 | METHOD FOR SYNTHESIZING CONFORMATIONALLY CONSTRAINED PEPTIDES, PEPTIDOMIMETICS AND THE USE THEREOF AS SYNTHETIC VACCINES - The present invention relates to methods for synthesizing conformationally constrained peptides and cyclic peptidomimetics obtainable by these methods which are conformationally constrained due an internal cross-link. This cross-link is formed between the side chain of an amino acid residue or analog and a (2S, 4S)4-functionalized proline residue. The invention further relates to the use of (2S, 4S)-4-functionalized proline residues as building units in the synthesis of such peptidomimetics and to the use thereof as antigens, alone or in combination with suitable immunopotentiating delivery systems, for example immunopotentiating reconstituted influenza virosomes to elicit an immune response in a mammal. Moreover, the invention also relates to pharmaceutical compositions containing the same. | 01-13-2011 |
Ursula Klause, Peissenberg DE
Patent application number | Description | Published |
---|---|---|
20110151581 | TRIGGER ASSAY FOR DIFFERENTIATING BETWEEN RHEUMATIC AND NON-RHEUMATIC DISORDERS - The present invention provides for a method for excluding a non-rheumatic disorder as cause of a musculoskeletal complaint of a subject including determining as to whether at least one autoantibody or antigen which is indicative for at least one rheumatic disorder is present in a sample obtained from the subject, wherein the presence of the autoantibody or antigen allows to exclude a non-rheumatic disorder as cause of a musculoskeletal complaint of a subject. Accordingly, it provides for a method that triggers the next steps in diagnosing the cause of a musculoskeletal complaint of a subject—either further diagnosis of a rheumatic disorder or of a non-rheumatic disorder to confirm the initial diagnosis. Also provided is a kit for excluding a non-rheumatic disorder as cause of a musculoskeletal complaint of a subject as well as uses of the kit. | 06-23-2011 |
20130121999 | BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR TREATMENT OF BREAST CANCER - The present invention provides methods for improving the treatment effect of a chemotherapy regimen of a patient suffering from breast cancer, in particular locally advanced, recurrent or metastatic HER-2 negative breast cancer, by adding bevacizumab (Avastin®) to a chemotherapy regimen by determining the expression level, in particular the blood plasma expression level, of one or more of VEGFA, VEGFR2 and PLGF relative to control levels of patients diagnosed with breast cancer, in particular locally advanced, recurrent or metastatic HER-2 negative breast cancer. In particular, the present invention provides methods of improving the treatment effect, wherein the treatment effect is the progression-free survival of the patient. The present invention further provides for methods for assessing the sensitivity or responsiveness of a patient to bevacizumab (Avastin®) in combination with a chemotherapy regimen, by determining the expression level, in particular the blood plasma expression level, of one or more of VEGFA, VEGFR2 and PLGF relative to control levels in patients diagnosed with breast cancer, in particular locally advanced, recurrent or metastatic HER-2 negative breast cancer. | 05-16-2013 |
20130183302 | BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR TREATMENT OF BREAST CANCER - The present invention provides methods for improving the treatment effect of a chemotherapy regimen of a patient suffering from breast cancer, in particular locally advanced, recurrent or metastatic HER-2 negative breast cancer, by adding bevacizumab (Avastin®) to a chemotherapy regimen by determining the expression level, in particular the blood plasma expression level, of one or more of VEGFA, VEGFR2 and PLGF relative to control levels of patients diagnosed with breast cancer, in particular locally advanced, recurrent or metastatic HER-2 negative breast cancer. In particular, the present invention provides methods of improving the treatment effect, wherein the treatment effect is the progression-free survival of the patient. The present invention further provides for methods for assessing the sensitivity or responsiveness of a patient to bevacizumab (Avastin®) in combination with a chemotherapy regimen, by determining the expression level, in particular the blood plasma expression level, of one or more of VEGFA, VEGFR2 and PLGF relative to control levels in patients diagnosed with breast cancer, in particular locally advanced, recurrent or metastatic HER-2 negative breast cancer. | 07-18-2013 |
20130183303 | BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR TREATMENT OF BREAST CANCER - The present invention provides methods for improving the treatment effect of a chemotherapy regimen of a patient suffering from breast cancer, in particular locally advanced, recurrent or metastatic HER-2 negative breast cancer, by adding bevacizumab (Avastin®) to a chemotherapy regimen by determining the expression level, in particular the blood plasma expression level, of one or more of VEGFA, VEGFR2 and PLGF relative to control levels of patients diagnosed with breast cancer, in particular locally advanced, recurrent or metastatic HER-2 negative breast cancer. In particular, the present invention provides methods of improving the treatment effect, wherein the treatment effect is the progression-free survival of the patient. The present invention further provides for methods for assessing the sensitivity or responsiveness of a patient to bevacizumab (Avastin®) in combination with a chemotherapy regimen, by determining the expression level, in particular the blood plasma expression level, of one or more of VEGFA, VEGFR2 and PLGF relative to control levels in patients diagnosed with breast cancer, in particular locally advanced, recurrent or metastatic HER-2 negative breast cancer. | 07-18-2013 |
Ursula Koniges, Brooklyn, NY US
Patent application number | Description | Published |
---|---|---|
20120295805 | SOLID PHASE METHODS FOR THERMODYNAMIC AND KINETIC QUANTIFICATION OF INTERACTIONS BETWEEN NUCLEIC ACIDS AND SMALL MOLECULES - Methods for analysis of interactions between nucleic acid-binding agents (BAs) and nucleic acids (NAs) by performance of nucleic acid denaturation assays on solid supports. Typically, BA is a small molecule less than 1000 g/gmol in molecular weight. The methods provide quantitative thermodynamic and kinetic analysis of BA-NA interaction; for example, in the form of free energies, enthalpies, and entropies of BA-NA binding in case of thermodynamic analysis, or in the form of rate constants and activation energies of BA-NA binding in the case of kinetic analysis. Examples of BAs of interest include transcription regulators and other NA-recognition molecules such as dyes and drug potentiators, DNA-targeted therapeutic agents including anticancer, antibiotic, antiviral, and antitrypanosomal compounds, carcinogens, and any other molecules whose interaction with DNA may, or is suspected to, lead to a biologically-relevant consequence. BA may bind to NA either through physical interactions or through formation of covalent adducts. | 11-22-2012 |
Ursula La Cognata, Berlin DE
Patent application number | Description | Published |
---|---|---|
20100189870 | STARCHES WITH HIGH AMYLOSE CONTENT AND IMPROVED PROCESSING PROPERTIES. - The present invention relates to maize starches with an apparent amylose content between 35 wt. % and 90 wt. % and improved processing properties relative to conventional high-amylose maize starches. Furthermore, the present invention relates to maize meals and foodstuffs containing these maize starches or maize meals. In addition, the present invention relates to methods of production of said maize starches/maize meals and maize plants which synthesize these maize starches. Moreover, the present invention relates to wheat starches with an apparent amylose content between 35 wt. % and 90 wt. % and improved processing properties, and wheat meals and foodstuffs containing said wheat starches or wheat meals. Moreover, the present invention relates to methods of production of said wheat starches/wheat meals and wheat plants which synthesize these wheat starches. | 07-29-2010 |
Ursula Lanin, Frankfurt Am Main DE
Patent application number | Description | Published |
---|---|---|
20120123351 | Needle Assembly - A needle assembly ( | 05-17-2012 |
Ursula Linnenschmidt, Sinzheim DE
Patent application number | Description | Published |
---|---|---|
20080202453 | Electronic Module Fox A Fan Of An Internal Combustion Engine In A Motor Vehicle - The invention relates to an electronic module ( | 08-28-2008 |
Ursula Lombrink, Landskrona SE
Patent application number | Description | Published |
---|---|---|
20120199249 | FLOOR TREATMENT - A method for treating a wooden, bamboo and/or cork floor treated with at least one maintenance material and a treated wooden, bamboo and/or cork floor obtained by the method. The method comprises applying a stripping formula on the wooden, bamboo and/or cork floor; allowing the stripping formula to interact with the at least one maintenance material; applying mechanical treatment to release the at least one maintenance material; and removing the at least one maintenance material and the stripping formula. | 08-09-2012 |
Ursula Luterbacher, Reinach CH
Patent application number | Description | Published |
---|---|---|
20100168291 | MONOAZO COLORANTS FOR MASS-COLOURING OF POLYMERS - A process for mass-colouring high molecular weight material, in which process a compound of formula | 07-01-2010 |
20100305247 | MONOAZO COLORANTS FOR MASS-COLOURING OF POLYMERS - A process for mass-colouring high molecular weight material, in which process a compound of formula (I) or a tautomer thereof, wherein M | 12-02-2010 |
20110294385 | ORGANIC BLACK PIGMENTS AND THEIR PREPARATION - A process for preparing a black colorant, preferably a black pigment, characterized in that a compound of the Formula (I) is reacted with a compound of the Formula (II) in a molar ratio of 1:2, in the presence of a catalyst which in water at 25° C. has a pK≦4.5. For the definition of R | 12-01-2011 |
20120172529 | MIGRATION-FREE COLOURED COPOLYCONDENSATES FOR COLOURING POLYMERS - The invention relates to coloured and/or fluorescent copolycondensates which are obtained by reaction of colourants substituted by at least two reactive groups which do not interfere with one another, with selected cyclic dicarboxylic acids (especially 1,4-cyclohexanedicarboxylic acid), aliphatic diols (especially ethylene glycol), cyclic diamines (especially isophoronediamine) and/or amino acids in particular amounts. | 07-05-2012 |
Ursula Maczkiewitz, Essen DE
Patent application number | Description | Published |
---|---|---|
20080260675 | Depolymerized Scleroglucan for Regulating and Improving the Moisture Content of the Skin - The use of depolymerized scleroglucan alone, or in combination with one or more active ingredients as a moisturizer, and as anti-inflammatory active ingredient for protecting and for restoring a healthy skin barrier in the field of cosmetic or dermatological skincare is disclosed. | 10-23-2008 |
20090104294 | BIOACTIVE COMPOSITION FOR COSMETIC APPLICATIONS - The invention relates to a process for the preparation of a plant extract from | 04-23-2009 |
20100266512 | CROSSLINKED HYALURONIC ACID IN EMULSION - The present invention relates to methods of producing crosslinked hyaluronic acid microbeads, as well as the produced microbeads, said method comprising the steps of: (a) providing an aqueous alkaline solution comprising hyaluronic acid, or a salt thereof; (b) forming microdroplets having a desired size from the mixed solution of step (a) in an organic or oil phase to form a water in organic or water in oil (VWO) emulsion, wherein the amount of oil phase used is of from 20 to less than 50% by weight based on the sum of oil phase and water; (c) adding a solution comprising a crosslinking agent to the emulsion, whereby the reaction of hyaluronic acid with the crosslinking agent takes place to provide crosslinked hyaluronic acid microbeads; and (d) optionally working up the dispersion of crosslinked hyaluronic acid microbeads obtained in step (c). | 10-21-2010 |
20110117219 | HAIR TREATMENT PRODUCT AND HAIR AFTER-TREATMENT PRODUCT CONTAINING ETHER GUANIDINES AS ACTIVE SUBSTANCES, FOR PROTECTING FROM DAMAGE CAUSED BY CHEMICAL TREATMENT AND FOR REPAIRING ALREADY DAMAGED HAIR - The invention relates to ether guanidines of the general formulae (I) | 05-19-2011 |
20110206623 | NOVEL DIPOLAR IONIC COMPOUNDS COMPRISING FORMULATIONS AND THE USE THEREOF - A subject-matter of the invention is formulations comprising novel zwitterionic compounds and the use of these formulations as cosmetics. | 08-25-2011 |
20110217400 | BIOACTIVE COMPOSITION FOR COSMETIC APPLICATIONS - The invention relates to a process for the preparation of a plant extract from | 09-08-2011 |
20120134948 | ANTIMICROBIAL ETHER GUANIDINES - The present invention relates to the use of at least one ether guanidine of the general formula (I) | 05-31-2012 |
20120244094 | TETRAPEPTIDES FOR BRIGHTENING THE SKIN - The invention relates to the use of the tetrapeptide PKEK for brightening human skin, for bleaching pigmented spots and/or for leveling out irregularities in skin coloration. | 09-27-2012 |
20120258155 | CROSSLINKED HYALURONIC ACID IN EMULSION - The present invention relates to methods of producing crosslinked hyaluronic acid microbeads, as well as the produced microbeads, said method comprising the steps of: | 10-11-2012 |
20150044158 | METHIONYL-METHIONINE STEREOISOMERS AND USE THEREOF IN COSMETICS - The present invention relates to a cosmetic formulation comprising certain methionyl-methionine stereoisomers and to the use of methionyl-methionine for nail and/or hair treatment. | 02-12-2015 |
Ursula Mais-Paul, Vienna AT
Patent application number | Description | Published |
---|---|---|
20100226907 | PURIFICATION OF BUTYRYLCHOLINESTERASE USING MEMBRANE ADSORPTION - The present invention relates to purification of butyrylcholinesterase using anion exchange material, where the butyrylcholinesterase content is enriched at least 10 fold per total protein in the composition. | 09-09-2010 |
Ursula Manuelpillai, Victoria AU
Patent application number | Description | Published |
---|---|---|
20100266552 | TREATMENT OF CHRONIC LUNG DISEASE - A method of cellular therapy for a lung disease or condition in a subject is disclosed, wherein the method involves the administration of multipotent epithelial stem cells derived from amnion tissue (AECs). In a particular application, the method is used for the treatment of lung diseases and conditions such as chronic lung diseases including chronic obstructive pulmonary disease (COPD), acute lung conditions such as acute respiratory distress syndrome (ARDS), and ventilator associated lung injury (VALI). | 10-21-2010 |
Ursula Meyer, Villach-Landskron AT
Patent application number | Description | Published |
---|---|---|
20140021610 | CHIP PACKAGE AND A METHOD FOR MANUFACTURING A CHIP PACKAGE - A chip package is provided, the chip package including: first encapsulation structure; first passivation layer formed over first encapsulation structure and first electrically conductive layer formed over first passivation layer; at least one chip arranged over first electrically conductive layer and passivation layer wherein at least one chip contact pad contacts first electrically conductive layer; at least one cavity formed in first encapsulation structure, wherein at least one cavity exposes a portion of first passivation layer covering at least one chip contact pad; second encapsulation structure disposed over first encapsulation structure and covering at least one cavity, wherein a chamber region over at least one chip contact pad is defined by at least one cavity and second encapsulation structure; wherein second encapsulation structure includes an inlet and outlet connected to chamber region, wherein inlet and outlet control an inflow and outflow of heat dissipating material to and from chamber region. | 01-23-2014 |
Ursula Moenning, Woltersdorf DE
Patent application number | Description | Published |
---|---|---|
20090030010 | 3-Amino-pyrazolo[3,4b]pyridines as inhibitors of protein tyrosine kinases, their production and use as pharmaceutical agents - This invention relates to compounds of general formula I | 01-29-2009 |
20110243846 | BENZOTHIAZOLE AMIDES FOR DETECTION OF AMYLOID BETA - This invention relates to compounds (benzothiazoles) suitable for labelling or already labelled by | 10-06-2011 |
Ursula Müller, Herzberg Am Harz DE
Patent application number | Description | Published |
---|---|---|
20110086202 | NEGATIVE-WORKING IMAGEABLE ELEMENTS - Negative-working imageable elements can be imaged and processed to provide lithographic printing plates. These imageable elements are sensitive to infrared radiation but are insensitive to “white” light and thus can be more easily handled under white light conditions. These properties are possible by incorporating a filter dye having a λ | 04-14-2011 |
Ursula Müller, Russelsheim DE
Patent application number | Description | Published |
---|---|---|
20120038131 | AIRBAG MODULE AND SEAT RELATED THERETO, AND ALSO MANUFACTURING APPARATUS AND ASSEMBLY METHOD THEREFOR - The invention relates to an airbag module ( | 02-16-2012 |
Ursula Müller, Herzberg Am Harz DE
Patent application number | Description | Published |
---|---|---|
20090011363 | Photopolymer Composition Usable for Lithographic Plates - Radiation-sensitive element comprising a substrate and a radiation-sensitive coating comprising (a) at least one component selected from photoinitiators and sensitizer/coinitiator systems which absorbs radiation of a wavelength in the range of 250 to 1,200 nm; (b) at least one free-radical polymerizable oligomer A having an average molecular weight in the range of 3,500 to 9,000 determined by GPC, obtainable by reacting a triisocyanate with (i) at least one acrylic or methacrylic monomer with two free OH groups and at least one (meth)acrylic group and (ii) at least one compound comprising one OH group, at least one (meth)acrylic group and at least one poly(alkyleneoxide) chain in the molecule, wherein the (meth)acrylic monomer (i) is present in an amount of 2 to 20 mole-%, based on the total amount of (meth)acrylic compounds with OH functionality. | 01-08-2009 |
20110086202 | NEGATIVE-WORKING IMAGEABLE ELEMENTS - Negative-working imageable elements can be imaged and processed to provide lithographic printing plates. These imageable elements are sensitive to infrared radiation but are insensitive to “white” light and thus can be more easily handled under white light conditions. These properties are possible by incorporating a filter dye having a λ | 04-14-2011 |
20120015295 | INFRARED-SENSITIVE COMPOSITION FOR PRINTING PLATE PRECURSORS - A lithographic printing plate precursor has a substrate and an infrared radiation-sensitive composition comprising a polymeric binder, a free radical polymerizable system consisting of at least one polymerizable component, a compound capable of absorbing infrared radiation, and an initiator system comprising an iodonium salt that is capable of producing free radicals; and at least 1% and up to and including 10% by weight, based on the infrared-sensitive composition, of at least one mono- or polycarboxylic acid having an aromatic moiety. | 01-19-2012 |
Ursula Müller-Vieira, Saarbrücken DE
Patent application number | Description | Published |
---|---|---|
20090221591 | Selective Inhibitors of Human Corticosteroid Synthases - The invention relates to compounds for selectively inhibiting human corticosteroid synthases CYP1 1 B1 and CYP1 1 B2, and to the production and use thereof for treating hypercortisolism, diabetes mellitus, hyperaldosteronism, cardiac insufficiency, myocardial fibrosis, depression, age-related cognitive decline and metabolic syndrome. | 09-03-2009 |
Ursula Müller-Vieira, Saarbrücken DE
Patent application number | Description | Published |
---|---|---|
20090221591 | Selective Inhibitors of Human Corticosteroid Synthases - The invention relates to compounds for selectively inhibiting human corticosteroid synthases CYP1 1 B1 and CYP1 1 B2, and to the production and use thereof for treating hypercortisolism, diabetes mellitus, hyperaldosteronism, cardiac insufficiency, myocardial fibrosis, depression, age-related cognitive decline and metabolic syndrome. | 09-03-2009 |
Ursula Muller-Viera, Ingbert DE
Patent application number | Description | Published |
---|---|---|
20090105278 | Selective inhibitors of human corticosteroid syntheses - The invention relates to compounds for selectively inhibiting human corticosteroid syntheses CYP11B1 and CYP11B2, to the production thereof and to their use for treating hypercortisolism and diabetes mellitus or insufficiency of the heart and myocardial fibrosis. | 04-23-2009 |
Ursula Nielinger, Krefeld DE
Patent application number | Description | Published |
---|---|---|
20090202805 | WATER-ABSORBING POLYMER STRUCTURES WITH IMPROVED ABSORPTION PROPERTIES - The present invention relates to a process for production of water-absorbing polymer structures comprising the process steps: | 08-13-2009 |
20140350191 | WATER-ABSORBING POLYMER STRUCTURE HAVING IMPROVED PERMEABILITY AND ABSORPTION UNDER PRESSURE - The present invention relates to a process for the preparation of water-absorbing polymer structures, comprising the following process steps: | 11-27-2014 |
Ursula Patwal, Reinheim/georgenhausen DE
Patent application number | Description | Published |
---|---|---|
20090201457 | LIQUID-CRYSTALLINE MIXTURES AND LIQUID-CRYSTAL DISPLAYS - The present invention relates to liquid-crystalline mixtures and to novel compounds therefor, and to the use thereof in nematic liquid-crystal displays having positive dielectric anisotropy, such as, for example, STN or IPS displays, which are characterised in that they comprise one or more compounds of the formula (I) in which R | 08-13-2009 |
Ursula Paulus-Rodatz, Landshut DE
Patent application number | Description | Published |
---|---|---|
20110033771 | ELECTRODE FOR MOLTEN CARBONATE FUEL CELL AND METHOD FOR ITS PRODUCTION - The present invention relates to an electrode for a molten carbonate fuel cell, with an electrochemically active electrode layer ( | 02-10-2011 |
20120208107 | ELECTRODE FOR A MOLTEN CARBONATE FUEL CELL AND METHOD FOR THE PRODUCTION THEREOF - The invention relates to an electrode for a molten carbonate fuel cell, having an electrode framework and an active layer comprising pores which is applied to the electrode framework. According to the invention, the active layer contains at least one structure stabilizer. The invention also relates to a method for producing said type of electrode. | 08-16-2012 |
Ursula Puntener, Baden CH
Patent application number | Description | Published |
---|---|---|
20090010921 | Antigen binding molecules with increased Fc receptor binding affinity and effector function - The present invention relates to antigen binding molecules (ABMs). In particular embodiments, the present invention relates to recombinant monoclonal antibodies, including chimeric, primatized or humanized antibodies specific for human CD20. In addition, the present invention relates to nucleic acid molecules encoding such ABMs, and vectors and host cells comprising such nucleic acid molecules. The invention further relates to methods for producing the ABMs of the invention, and to methods of using these ABMs in treatment of disease. In addition, the present invention relates to ABMs with modified glycosylation having improved therapeutic properties, including antibodies with increased Fc receptor binding and increased effector function. | 01-08-2009 |
Ursula Rammelt, Dresden DE
Patent application number | Description | Published |
---|---|---|
20080305341 | Process for Coating Metallic Surfaces With an Anti-Corrosive Coating - A process is disclosed for coating metallic surfaces with an anti-corrosive composition that contains a conductive polymer and is a dispersion that contains the at least one conductive polymer mainly or entirely in particulate form, as well as a binder system. The conductive polymer is at least one polymer based on polyphenylene, polyfuran, polyimidazole, polyphenanthrene, polypyrrole, polythiophene and/or polythiophenylene charged with anti-corrosive mobile anions. Alternatively, the metallic surfaces can be first coated with a dispersion based on conductive polymers in particulate form, then coated with a composition which contains a binder system. | 12-11-2008 |
20120208086 | PROCESS FOR COATING FINE PARTICLES WITH CONDUCTIVE POLYMERS - A process for coating fine particles, in which the feed mixture contains: a monomer and/or an oligomer of aromatic compounds or unsaturated hydrocarbon compounds suitable for forming an electroconductive oligomer, polymer, copolymer, block copolymer or graft copolymer; at least one type of anions which (1) are and/or can be incorporated as doping ions into the structure of the conductive polymer; (2) can be discharged from said structure in the event of a potential fall of the conductive polymer (reduction); and (3) can have an anti-corrosive effect in the presence of a metallic surface; at least one type of particles; if necessary, at least one oxidising agent and water and/or at least another solvent. A coating is formed from the feed mixture on the particle surface, the feed mixture being converted by oxidation into a conductive polymer in the presence of at least one type a of mobile anti-corrosive anion. | 08-16-2012 |
Ursula Rauen, Essen DE
Patent application number | Description | Published |
---|---|---|
20110300237 | Protective solutions for organs - Described is a protective solution for avoiding ischemic, storage or ischemia/reperfusion to organs, or to isolated cell systems, or to tissue components after perfusion, surgery, transplantation, or cryopreservation and subsequent reperfusion, which contains alkali ions, and if need be also alkaline earth ions as the electrolyte, a buffer e.g. on a histidine derivation basis, as well as a polyol and/or a saccharide, has an osmolarity of about 290 mosm/l to about 350 mosm/l, as well as a pH value of about 6.8 to about 7.4, and to which hydroxamic acid, and/or one or more hydroxamic acid derivatives are added. | 12-08-2011 |
Ursula Ravens, Dresden DE
Patent application number | Description | Published |
---|---|---|
20110081721 | PROCESS FOR PRODUCING A TISSUE TRANSPLANT CONSTRUCT FOR RECONSTRUCTING A HUMAN OR ANIMAL ORGAN - A process for producing a tissue transplant construct for reconstructing a human or animal organ. The process may include the steps of: (a) isolation and two-dimensional cultivation of organ-specific tissue cells; (b) application of the organ-specific tissue cells to a biocompatible, collagen-containing membrane; and, (c) cultivation of the organ-specific tissue cells on the membrane with biochemical and mechanical stimulation of the organ-specific tissue cells. Tissue transplant constructs and methods for using tissue transplant constructs are also taught. | 04-07-2011 |
Ursula Schaf, Markgroeningen DE
Patent application number | Description | Published |
---|---|---|
20090278385 | Vehicle Body - A vehicle body of a motor vehicle has a central tunnel which is connected on its open lower side to at least one transverse bridge support. The bridge support is mounted to the lower side of bent limb portions of the central tunnel and is connected via at least two bolted connections, which are offset in the longitudinal and transverse directions of the vehicle, to a supporting bracket arranged on the upper side of the bent limb portions. The bridge support together with the supporting bracket faces an end side of the seat crossmember in an exposed manner. Furthermore, two bridge supports which are connected to each other via longitudinal struts can be provided on the central tunnel. | 11-12-2009 |
20100026046 | STIFFENING DEVICE FOR A MOTOR VEHICLE - A stiffening device for a motor vehicle body with a U-shaped central tunnel. The stiffening device includes a tunnel bridge with at least two transverse beams and, connected thereto, longitudinal beams. The transverse beams extend underneath the central tunnel and can be fastened with a free end in each case to the vehicle body by connecting devices. | 02-04-2010 |
20100026052 | Vehicle Body with a Floor-Side Reinforcement - A vehicle body has a floor-side reinforcement, in particular crash reinforcement structure, laterally on both sides of the central tunnel, for a transmission support. The transmission support is arranged between reinforcement elements of the vehicle floor which are held so as to be situated opposite on the vehicle floor interior and on the vehicle floor exterior respectively. Outer lateral longitudinal edges of the reinforcement elements are connected to floor longitudinal beams and inner lateral longitudinal edges are connected to transmission longitudinal beams which are held so as to be supported at the central tunnel. | 02-04-2010 |
Ursula Schäf, Markgroeningen DE
Patent application number | Description | Published |
---|---|---|
20100026052 | Vehicle Body with a Floor-Side Reinforcement - A vehicle body has a floor-side reinforcement, in particular crash reinforcement structure, laterally on both sides of the central tunnel, for a transmission support. The transmission support is arranged between reinforcement elements of the vehicle floor which are held so as to be situated opposite on the vehicle floor interior and on the vehicle floor exterior respectively. Outer lateral longitudinal edges of the reinforcement elements are connected to floor longitudinal beams and inner lateral longitudinal edges are connected to transmission longitudinal beams which are held so as to be supported at the central tunnel. | 02-04-2010 |
Ursula Schloetzer, Erlangen DE
Patent application number | Description | Published |
---|---|---|
20090220469 | PEPTIDES AGAINST AUTOANTIBODIES ASSOCIATED WITH GLAUCOMA AND USE OF THESE PEPTIDES - The invention relates to nucleic acid molecules encoding peptides which interact with autoantibodies associated with glaucoma, to the peptides themselves, to a pharmaceutical composition comprising said nucleic acid molecules and peptides, and to the use of said peptides—especially in apheresis—for the treatment of glaucoma. | 09-03-2009 |
Ursula Schmidt, Alzenau DE
Patent application number | Description | Published |
---|---|---|
20110294234 | THIN FILM SOLAR FABRICATION PROCESS, ETCHING METHOD, DEVICE FOR ETCHING, AND THIN FILM SOLAR DEVICE - Methods and devices for etching a device precursor are provided. For example, a method includes: providing a substrate, determining a temperature associated with the substrate, and etching a metal oxide layer of the substrate, wherein the etching is controlled based on the determined temperature. | 12-01-2011 |
Ursula Schmitt, Assmannshardt DE
Patent application number | Description | Published |
---|---|---|
20100099055 | Dental Laser Treatment Instrument Comprising an Optical Extraction Element - A dental laser treatment instrument comprising a handpiece that is connected to a supply tube for supplying laser radiation and a treatment fluid, and has a long extraction element on the front end thereof, for emitting the laser radiation. The extraction element has a long optical fiber and a cylindrical or sleeve-type holding element which surrounds the optical fiber in a region facing the front end of the fiber, at a distance from said fiber, in order to form a fluid channel. The fluid channel is connected to a supply line extending through the handpiece. According to the invention, the sleeve-type holding element projects past the front optical output end of the optical fiber. | 04-22-2010 |
20100323318 | Laser Handpiece - A laser handpiece, which has an outer guide sleeve in which a light guide is contained, is provided with a releasable clamping device. By the rotation of a rotary ring on the guide sleeve, the clamping device can be released and an advancing of the light guide, either manually or automatically, can be guaranteed. | 12-23-2010 |
Ursula Schulze Tilling, Muenster DE
Patent application number | Description | Published |
---|---|---|
20120279566 | PHOTOVOLTAIC ELEMENT WITH INCREASED LONG-TERM STABILITY - A photovoltaic element for conversion of electromagnetic radiation to electrical energy, having at least one first electrode, at least one n-semiconductive metal oxide, at least one dye for absorption of electromagnetic radiation, at least one organic hole conductor material, and at least one second electrode. The organic hole conductor material has an absorption spectrum which has a maximum in the ultraviolet or blue spectral region and, toward higher wavelengths, an absorption edge declining with wavelength and having a characteristic wavelength λ | 11-08-2012 |
Ursula Staubli, Laguna Beach, CA US
Patent application number | Description | Published |
---|---|---|
20120329851 | D-SERINE TRANSPORTER INHIBITORS AS PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS - The present invention relates to pharmaceutical compositions comprising D-serine transporter inhibitors and therapeutic methods using such pharmaceutical compositions in methods for the treatment of central nervous system disorders. | 12-27-2012 |
20130197002 | BRIMONIDINE FOR TREATING VISUAL DISORDERS MEDIATED BY CENTRAL VISUAL PROJECTIONS FROM THE EYE - The present invention relates to a method for treating visual disorders mediated by lateral geniculate nucleus, superior colliculus and the visual cortex by administering to a patient in need of such treatment, compounds acting at the alpha 2 adrenergic receptor. | 08-01-2013 |
20140200254 | D-SERINE TRANSPORTER INHIBITORS AS PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS - The present invention relates to pharmaceutical compositions comprising D-serine transporter inhibitors and therapeutic methods using such pharmaceutical compositions in methods for the treatment of central nervous system disorders. | 07-17-2014 |
Ursula Weidig, Kassel DE
Patent application number | Description | Published |
---|---|---|
20100000073 | METHOD OF PRODUCING AT LEAST TWO PLANE FUNCTIONAL SURFACES EXTENDING PARALLEL TO EACH OTHER ON A PIPE - The object of the invention is a method for producing at least two plane functional surfaces extending parallel to each other on a pipe ( | 01-07-2010 |
Ursula Wensorra, Hamburg DE
Patent application number | Description | Published |
---|---|---|
20130253068 | Cosmetic or Dermatological Preparations Containing Licochalcone A or an Extract of Radix Glycyrrhizae inflatae, Containing Licochalcone A - Disclosed are cosmetic or dermatological preparations for the treatment or alleviation of erythema which comprise an aqueous extract of Radix | 09-26-2013 |
Ursula Westerholt, Essen DE
Patent application number | Description | Published |
---|---|---|
20130171087 | COMPOSITION COMPRISING MIXTURES OF ISOSTEARAMIDE, GLYCEROL ESTER AND WATER - The present invention is directed to compositions comprising a mixture comprising at least one isostearamide, at least one glycerol ester and water, and also to the use of these compositions as thickeners or shampoos, conditioners, shower gels, body cleaning compositions or skin cleaning compositions or for producing shampoos, conditioners, shower gels, body cleaning compositions or skin cleaning compositions. | 07-04-2013 |
20130204021 | POLYGLYCOL ETHER-FREE SULPHOSUCCINATES BASED ON POLYGLYCEROL PARTIAL ESTERS AND USE THEREOF - The invention relates to polyglycol ether-free, polyglycerol partial ester-based sulphosuccinates, the preparation thereof, and the use of these in cosmetic formulations and also in cleaning compositions in the industrial and domestic sector and formulations comprising these sulphosuccinates. | 08-08-2013 |
20140286889 | FORMULATION COMPRISING ESTER QUATS BASED ON ISOPROPANOLAMINE - Cosmetic formulations including specific ester quats based on isopropanolamine are provided, as well as the use of these ester quats in cosmetics. | 09-25-2014 |
Ursula Wolf, Darmstadt DE
Patent application number | Description | Published |
---|---|---|
20080208038 | Method and Device For Representing the Microstructure of the Lungs - The invention relates to an apparatus and a method for imaging the microstructure of an animal or human lung by way of introducing a fluoric contrast gas into the lung which is to be imaged; definition of the apparent diffusion coefficient of the contrast gas by way of diffusion weighted | 08-28-2008 |